TY  - GEN
AU  - Herrmann,Christina
AU  - Abel,Ulrich
AU  - Stremmel,Wolfgang
AU  - Jaeger,Dirk
AU  - Herrmann,Thomas
TI  - Short time to progression under first-line chemotherapy is a negative prognostic factor for time to progression and residual survival under second-line chemotherapy in advanced pancreatic cancer
SN  - 1423-0232
PY  - 2008///0801
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Capecitabine
KW  - Cohort Studies
KW  - Deoxycytidine
KW  - Disease Progression
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Palliative Care
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Prognosis
KW  - Survival Rate
KW  - Time Factors
KW  - Gemcitabine
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1159/000134477
ER  -